dipyridamole has been researched along with Infarction, Middle Cerebral Artery in 3 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dipyridamole (DP) is a platelet inhibitor with known antithrombotic benefits in stroke prevention." | 1.37 | Effects of acute post-treatment with dipyridamole in a rat model of focal cerebral ischemia. ( Boada, C; Campos, M; García-Bonilla, L; Hernández-Guillamon, M; Montaner, J; Penalba, A; Rosell, A; Sosti, V; Sumalla, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amtul, Z | 1 |
| Haque, W | 1 |
| Cechetto, DF | 1 |
| d'Esterre, CD | 1 |
| Lee, TY | 1 |
| García-Bonilla, L | 1 |
| Sosti, V | 1 |
| Campos, M | 1 |
| Penalba, A | 1 |
| Boada, C | 1 |
| Sumalla, M | 1 |
| Hernández-Guillamon, M | 1 |
| Rosell, A | 1 |
| Montaner, J | 1 |
1 review available for dipyridamole and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Effect of dipyridamole during acute stroke: exploring antithrombosis and neuroprotective benefits.
Topics: Animals; Cerebrovascular Circulation; Dipyridamole; Disease Models, Animal; Fibrinolytic Agents; Hum | 2010 |
2 other studies available for dipyridamole and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Dipyridamole plus Triflusal versus Triflusal Alone in Infarct Reduction after Middle Cerebral Artery Occlusion.
Topics: Animals; Brain; Cytoprotection; Dipyridamole; Disease Models, Animal; Dose-Response Relationship, Dr | 2018 |
Effects of acute post-treatment with dipyridamole in a rat model of focal cerebral ischemia.
Topics: Animals; Aquaporins; Brain; Brain Infarction; Chemokine CCL2; Dipyridamole; Disease Models, Animal; | 2011 |